Document Detail

Extracorporeal liver assist device: hope for the future.
MedLine Citation:
PMID:  7866895     Owner:  NLM     Status:  MEDLINE    
The liver has the unique property of regeneration in an acute setting if given enough time. Currently the only successful intervention for liver failure, both acute and chronic, is orthotopic liver transplantation. The increasing cost of transplantation and subsequent medical care, coupled with the decreasing availability of transplantable organs, magnifies the need for an alternative solution. A liver assist device that is metabolically similar to a native liver will advance the treatment regimen and decrease the need for surgery.
C Conlin
Related Documents :
15619025 - Cadaveric domino liver transplantation: the first case in japan.
7806175 - Failure of hepatopulmonary syndrome to resolve after liver transplantation and successf...
9828705 - Liver span--a comparative appraisal of various methods.
20671595 - Early renal failure after domino liver transplantation using organs from donors with pr...
407175 - Metrizamide in urography. ii. a comparison of 51cr-edta clearance and metrizamide clear...
21071545 - Risk factors for pneumocystis jiroveci pneumonia (pcp) in renal transplant recipients.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Critical care nursing quarterly     Volume:  17     ISSN:  0887-9303     ISO Abbreviation:  Crit Care Nurs Q     Publication Date:  1995 Feb 
Date Detail:
Created Date:  1995-03-30     Completed Date:  1995-03-30     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8704517     Medline TA:  Crit Care Nurs Q     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  73-8     Citation Subset:  N    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Artificial Organs* / adverse effects
Liver Failure / surgery*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Psychosocial considerations for bone marrow transplant recipients.
Next Document:  Mechanism of p53 gene mutation in the development of urologic cancer